International Journal of Clinical Science and Medical Research

The study's was conducted in the south  of Iraq (Nasiriyah Province), to detect relationship between (IL-18) gene polymorphism and H. pylori infections from the period  10/1/2021 to 1/3/2022, where 100 blood samples were collected H. pylori patients for the purpose of DNA extraction and identification of interleukin-18 polymorphisms . The results were as follows: The demographic and mdicale features of a whole of (100) patients were considered in this study, involving aged, sex, mean body weight, smoking, alcohol use, education, income level, and related to stomach cancer. There were 35 women and 65 men in the study group, respectively. The percentage of infection was highest in the population in rural areas, where the mean age was 53.9 10.8 years. Sequencing was performed on 30 randomly selected blood samples, and the results revealed that none of the samples had changed., Also found In this study the mutant heterozygous (TG) "rs 19465189"  were associated with higher levels of IL-18 and severe gastric inflammation compared with other genotypes .The results of sequencing by Macrogen Corporation, were uis alised V.7.2.6 program by Bioedit, as well as  and we made alignment using Clustal Omega tool available online.  the results showed there was compatibility between recorded  wolrd gene bank IL-18 polymorphism with IL-18 polymorphism in H. pylori patients in studied area.

interleukin-18(TG) "rs 19465189" gene, Helicobacter infection, Iraq

1. Nakamura, K.; Okamura, H.; Nagata, K.; Komatsu, T.; Tamur1993, 61, 64–70. a,  T. Purification of a Factor Which Provides a Costimulatory Signal.for Gamma Interferon Production. Infect. Immun. [CrossRef].
2. Dinarello, C.A.; Novick, D.; Kim, S.; Kaplanski, G. Interleukin-18 and IL-18 Binding Protein. Front. Immunol. 2013, 4, 289.[CrossRef].
3. Bazan, J.F.; Timans, J.C.; Kastelein, R.A. A Newly Defined Interleukin-1? Nature 1996, 379, 591. [CrossRef].
4. Gu, Y.; Kuida, K.; Tsutsui, H.; Ku, G.; Hsiao, K.; Fleming, M.A.; Hayashi, N.; Higashino, K.; Okamura, H.; Nakanishi, K.; et al. Activation of Interferon-Gamma Inducing Factor Mediated by Interleukin-1beta Converting Enzyme. Science 1997, 275, 206–209.[CrossRef]
5. Heilig, R.; Dick, M.S.; Sborgi, L.; Meunier, E.; Hiller, S.; Broz, P. The Gasdermin-D Pore Acts as a Conduit for IL-1_ Secretion inMice. Eur. J. Immunol. 2018, 48, 584–592. [CrossRef] [PubMed].
6. Brocker C, Thompson D, Matsumoto A, Nebert DW, Vasiliou V (Oct 2010). "Evolutionary divergence and functions of the human interleukin (IL) gene family". Human Genomics. 5 (1): 30–55. doi:10.1186/1479-7364-5-1-30. PMC 3390169. PMID 21106488.
7. Ben Menachem-Zidon O, Avital A, Ben-Menahem Y, Goshen I, Kreisel T, Shmueli EM, Segal M, Ben Hur T, Yirmiya R (Jul 2011). "Astrocytes support hippocampal-dependent memory and long-term potentiation via interleukin-1 signaling". Brain, Behavior, and Immunity. 25 (5): 1008–16. doi:10.1016/j.bbi.2010.11.007. PMID 21093580. S2CID 18300021.
8. di Giovine FS, Duff GW (Jan 1990). "Interleukin 1: the first interleukin". Immunology Today. 11 (1): 13–20. doi:10.1016/0167-5699(90)90005-t. PMID 2405873.
9. Schindler R, Dinarello CA (1990). "Interleukin 1". In Habenicht A (ed.). Growth Factors, Differentiation Factors, and Cytokines. Berlin, Heidelberg: Springer. pp. 85–102. doi:10.1007/978-3-642-74856-1_7. ISBN 978-3-642-74856-1.
10. "Revised nomenclature for antigen-nonspecific T cell proliferation and helper factors". Journal of Immunology. 123 (6): 2928–9. Dec 1979. PMID 91646.
11. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol.2001;19:423‐474.
12. Dinarello CA, Novick D, Kim S, Kaplanski G. Interleukin-18 and IL-18 binding protein. Front Immunol. 2013;4:289.
13. Dinarello CA, Novick D, Puren AJ, et al. Overview of interleukin-18: more than an interferon-gamma inducing factor. J Leukoc Biol. 1998;63:658‐664.
14. Gu Y, Kuida K, Tsutsui H, et al. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science. 1997;275:206‐209.
15. Ghayur T, Banerjee S, Hugunin M, et al. Caspase-1 processes IFN-gamma- inducing factor and regulates LPS-inducedIFN-gamma production. Nature. 1997;386:619‐623.
16. Jorgensen I, Miao EA. Pyroptotic cell death defends against intracellular pathogens. Immunol Rev. 2015;265:130‐142.
17. Tsutsui H, Kayagaki N, Kuida K, et al. Caspase-1- independent, Fas/ Fas ligand-   mediated IL-18 secretion from macrophages causes acute liver injury in mice. Immunity. 1999;11:359‐367.
18. Bossaller L, Chiang PI, Schmidt-Lauber C, et al. Cutting edge: FAS (CD95) mediates noncanonical IL-1β and IL-18 maturation via caspase-8 in an RIP3-independent manner. J Immunol. 2012;189:5508‐5512.
19. Akita K, Ohtsuki T, Nukada Y, et al. Involvement of caspase-1 and caspase-3 in the production and processing of mature human interleukin 18 in monocytic THP.1 cells. J Biol Chem. 1997;272:26595‐26603.
20. Omoto Y, Yamanaka K, Tokime K, et al. Granzyme B is a novel interleukin-converting enzyme. J Dermatol Sci. 2010;59:129‐135.
21. Okamura H, Kashiwamura S, Tsutsui H, Yoshimoto T, Nakanishi K. Regulation of interferon-gamma production by IL-12 and IL-18. Curr Opin Immunol. 1998;10:259-264.  [PubMed]  [DOI]  [Cited in This Article: 2]  [Cited by in Crossref: 363]  [Cited by in F6Publishing: 101]  [Article Influence: 15.1]  [Reference Citation Analysis (0)].
22. Dinarello CA, Novick D, Kim S, Kaplanski G. Interleukin-18 and IL-18 binding protein. Front Immunol. 2013;4:289.  [PubMed]  [DOI]  [Cited in This Article: 1]  [Cited by in Crossref: 330]  [Cited by in F6Publishing: 358]  [Article Influence: 36.7]  [Reference Citation Analysis (0)].
23. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol. 2001;19:423-474.  [PubMed]  [DOI]  [Cited in This Article: 1]  [Cited by in Crossref: 879]  [Cited by in F6Publishing: 830]  [Article Influence: 41.9]  [Reference Citation Analysis (0)].
24. Esposito K, Nappo F, Giugliano F, Di Palo C, Ciotola M, Barbieri M, Paolisso G, Giugliano D. Cytokine milieu tends toward inflammation in type 2 diabetes. Diabetes Care. 2003;26:1647.  [PubMed]  [DOI]  [Cited in This Article: 1]  [Cited by in Crossref: 71]  [Cited by in F6Publishing: 54]  [Article Influence: 3.7]  [Reference Citation Analysis (0)].
25. Blankenberg S, Tiret L, Bickel C, Peetz D, Cambien F, Meyer J, Rupprecht HJ. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation. 2002;106:24-30.  [PubMed]  [DOI]  [Cited in This Article: 2]  [Cited by in Crossref: 377]  [Cited by in F6Publishing: 95]  [Article Influence: 18.9]  [Reference Citation Analysis (0)].
26. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106:2067-2072.  [PubMed]  [DOI]  [Cited in This Article: 1]  [Cited by in Crossref: 1183]  [Cited by in F6Publishing: 484]  [Article Influence: 59.2]  [Reference Citation Analysis (0)].
27. Moriwaki Y, Yamamoto T, Shibutani Y, Aoki E, Tsutsumi Z, Takahashi S, Okamura H, Koga M, Fukuchi M, Hada T. Elevated levels of interleukin-18 and tumor necrosis factor-alpha in serum of patients with type 2 diabetes mellitus: relationship with diabetic nephropathy. Metabolism. 2003;52:605-608. [PubMed]  [DOI]  [Cited in This Article: 1]  [Cited by in Crossref: 174]  [Cited by in F6Publishing: 164]  [Article Influence: 9.2]  [Reference Citation Analysis (0)].
28. Hung J, McQuillan BM, Chapman CM, Thompson PL, Beilby JP. Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance. Arterioscler Thromb Vasc Biol. 2005;25:1268-1273.  [PubMed]  [DOI]  [Cited in This Article: 1]  [Cited by in Crossref: 147]  [Cited by in F6Publishing: 72]  [Article Influence: 8.6]  [Reference Citation Analysis (0)].
29. Kretowski A, Mironczuk K, Karpinska A, Bojaryn U, Kinalski M, Puchalski Z, Kinalska I. Interleukin-18 promoter polymorphisms in type 1 diabetes. Diabetes. 2002;51:3347-3349.  [PubMed]  [DOI]  [Cited in This Article: 3]  [Cited by in Crossref: 102]  [Cited by in F6Publishing: 101]  [Article Influence: 5.1]  [Reference Citation Analysis (0)].
30. Hirankarn N, Manonom C, Tangkijvanich P, Poovorawan Y. Association of interleukin-18 gene polymorphism (-607A/A genotype) with susceptibility to chronic hepatitis B virus infection. Tissue Antigens. 2007;70:160-
31. Mohammed M. A. Al-Fayadh1, Maani N. Al-Shemari1 and Ihsan E. Al-Saimary . Molecular characterization of antigens extracted from hydatid cysts of human and other intermediate hosts . Journal of Microbiology and Antimicrobials.2010. Vol. 2(7), pp. 76-82 . https://scholar.google.com/citations?user=_kOoApsAAAAJ&hl=en
32. Adnan Jawad Ahmed , Afrah Ali abd Al amer and Mohammed Mousa Atta . Inhibition Effect Of Pomegranate And Orange Peel Extract On The Growth Of Staphylococcus Aureus From Cheese . Nat. Volatiles & Essent. Oils, 2022; 9(1): 532-540. https://scholar.google.com/citations?user=_kOoApsAAAAJ&hl=en
33. Hamadi Aabttan Al-Hilali and Mohammed Mousa Atta . Measurements of Some Asthma Markers (IgE, IFNγ, IL-4 IL) by ELISA technique and FOXP3 and IL-10 Expression in Asthmatic Patients . Int.J.Curr.Microbiol.App.Sci (2016) 5(12): 903-909. https://scholar.google.com/citations?user=_kOoApsAAAAJ&hl=en